Nuveen’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-51,600
Closed -$10K – 3395
2021
Q1
$10K Buy
+51,600
New +$10.2M ﹤0.01% 3306
2020
Q2
– Sell
-20,400
Closed -$4K – 3286
2020
Q1
$4K Hold
20,400
– – ﹤0.01% 3159
2019
Q4
$4K Buy
+20,400
New +$4.18M ﹤0.01% 3199

Other funds holding CME

Nuveen's CME Position: Q3 2026 in Review

Nuveen reduced its CME Group (CME) stake by 0.28% in Q3 2026, selling an estimated $672K and leaving 923,433 shares worth $242M. The position accounts for 0.06% of the portfolio, ranked #237.

Nuveen first reported a position in CME in Q2 2013 and has held it in 54 quarters since. The position peaked at $663M in Q3 2019. 1,768 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Nuveen held 923,433 shares of CME Group worth $242M as of Q3 2026.
  • Nuveen sold 2,549 CME Group shares in Q3 2026, an estimated $672K.
  • CME Group made up 0.06% of Nuveen's portfolio in Q3 2026, its #237 holding.
  • Nuveen first reported a position in CME Group in Q2 2013 and has held it in 54 quarters since.
  • Nuveen's CME Group position peaked at $663M in Q3 2019.
  • 1,768 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.